Surfactant regulation of host defense function in the lung: A question of balance

Pediatric Pathology and Molecular Medicine

Volumn 20, Issue 4, 2001, Pages 269-292

  Phelps, D S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Innate immunity; Macrophage; Phagocytosis; SP A; SP D; Surfactant

Indexed keywords

CELL SURFACE MARKER; COLLECTIN; GLYCOCONJUGATE; LECTIN; LUNG SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ARTICLE; CELL PROLIFERATION; CHEMOTAXIS; HOST RESISTANCE; IMMUNOREGULATION; LUNG DISEASE; LUNG FUNCTION; LUNG INJURY; MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BACTERIAL INFECTIONS; BINDING SITES; CYTOKINES; GLYCOPROTEINS; HUMANS; IMMUNITY, NATURAL; IMMUNOCOMPETENCE; INFLAMMATION; LUNG; MACROPHAGES; MEMBRANE PROTEINS; MICE; PHAGOCYTOSIS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; VIRUS DISEASES;

EID: 0034973011     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/152279501750412225     Document Type: Article

References (115)

1. Innate immunity: Impact on the adaptive immune response
2. Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material
3. Surfactant: A review of its functions and relevance in adult respiratory disorders
4. Immunomodulatory functions of surfactant
5. Pulmonary surfactant in health and human lung diseases: State of the art
6. Collectins and pulmonary host defense
7. The roles of surfactant proteins A and D in innate immunity
8. Structural aspects of collectins and receptors for collectins
9. Human autoantibodies against Clq: Lack of cross-reactivity with the collectins mannan-binding protein, lung surfactant protein A and bovine conglutinin
10. Genetics of the hydrophilic surfactant proteins A and D
11. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36: Structural homology with the complement factor Clq
12. 5′ splicing and allelic variants of the human pulmonary surfactant protein A genes
13. Human SP-A locus: Allele frequencies and linkage disequilibrium between the two surfactant protein A genes
14. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles
15. Interactions of surfactant protein-D with bacterial lipopolysaccharides-surfactant protein-D is an Escherichia coli binding protein in bronchoalveolar lavage
16. Structural similarity between bovine conglutinin and bovine lung surfactant protein-D and demonstration of liver as a site of synthesis of conglutinin
17. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides
18. Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages
19. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14
20. Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells
21. Alveolar type II cells isolated after silica-induced lung injury in rats have increased surfactant protein A (SP-A) receptor activity
22. Purification of a cell-surface receptor for surfactant protein A
23. Interaction of Clq receptor with lung surfactant protein-A
24. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule
25. Exposure of surfactant protein-A to ozone in vitro and in vivo impairs its interactions with alveolar cells
26. Structural and functional changes of surfactant protein A induced by ozone
27. Characterization of radioiodinated lung surfactant protein A(SP-A) and the effect of oxidation on SP-A quaternary structure and activity
28. Nitration of surfactant protein A results in decreased ability to aggregate lipids
29. Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability
30. Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages
31. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro
32. Human lung surfactant protein A exists in several different oligomeric states: Oligomer size distribution varies between patient groups
33. Surfactant therapy in the USA: Trials and current routines
34. Regulation of surfactant protein D in human fetal lung
35. Effects of TNF-alpha and phorbol ester on human surfactant protein and MnSOD gene transcription in vitro
36. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth
37. Interleukin-1α upregulates the expression of surfactant protein-A in rabbit lung explants
38. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation
39. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide
40. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury
41. Alterations of the endogenous surfactant system in septic adult rats
42. Effect of air pollutants on the pulmonary surfactant system
43. Surfactant proteins and lipids are regulated independently during hyperoxia
44. Cell-specific alterations in expression of hyperoxia-induced mRNAs of lung
45. Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis
46. Survanta downregulates type I collagen, upregulates collagenase-1, and induces fibroblast apoptosis in vitro
47. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production
48. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1
49. Surfactant protein A activates NF-kB in the THP-1 monocytic cell line
50. Comparison of SP-A and LPS effects on the THP-1 monocytic cell line
51. Augmentation of rat alveolar macrophage migration by surfactant protein
52. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage
53. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages
54. Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes
55. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material
56. Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages
57. Human alveolar lining material and antibacterial defenses
58. Effect of rat surfactant lipids on complement and Fc receptors of macrophages
59. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages
60. Interaction of surfactant protein A with pathogens
61. Surfactant protein A and surfactant protein D in health and disease
62. Mechanisms of phagocytosis in macrophages
63. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection
64. Surfactant protein A enhances respiratory syncytial virus clearance in vivo
65. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice
66. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macro-phages
67. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria
68. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages
69. Interactions of surfactant protein A with influenza A viruses: Binding and neutralization
70. Binding of surfactant protein A (SP-A) to Herpes simplex virus Type 1-infected cells is mediated by the carbohydrate moiety of SP-A
71. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages
72. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus
73. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages
74. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages
75. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages
76. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages
77. Surfactant protein D mediates aggregation of Pneumocystis carinii
78. Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro
79. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat
80. Surfactant protein D binds to mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages
81. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages
82. Phagocytosis of viable candida albicans by alveolar macrophages: Lack of opsonin function of surfactant protein A
83. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens
84. Pollen grains bind to lung alveolar type-II cells (A549) via lung surfactant protein-A (SP-A)
85. Pulmonary surfactant and lung defense: Interactions of surfactant proteins with phagocytic cell and pathogens
86. A novel procedure for the rapid isolation of surfactant protein A with retention of its alveolar-macrophage-stimulating properties
87. Calcium dependent association of surfactant protein A with pulmonary surfactant: Application to simple surfactant protein A purification
88. Human SP-A protein variants derived from one or both genes stimulate TNF-a production in the THP-1 cell line
89. Rat surfactant protein-D enhances the production of oxygen radicals by rat alveolar macrophages
90. Monocytes incubated with surfactant: A model for human alveolar macrophages?
91. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes
92. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages
93. Immunosuppressive activity of canine pulmonary surface active material
94. Canine surface active material and pulmonary lymphocyte function: Studies with mixed-lymphocyte culture
95. Immunoregulatory properties of pulmonary surfactant: Effect of lung lining fluid on proliferation of human blood lymphocytes
96. Immunoregulatory properties of pulmonary surfactant: Influence of variations in the phospholipid profile
97. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis
98. Early effects of short-time cigarette smoking on the human lung-a study of bronchoalveolar lavage fluids
99. Loss of lymphocyte modulatory control by surfactant lipid extracts from acute hypersensitivity pneumonitis: Comparison with sarcoidosis and idiopathic pulmonary fibrosis
100. Immunogenicity and immunomodulatory activity of bovine surfactant (SF-RI 1)
101. In vitro lymphocyte functions in the presence of bovine surfactant and its phospholipid fractions
102. The effect of three surfactant preparations on in vitro lymphocyte functions
103. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro
104. Surfactant associated protein A inhibits human lymphocyte proliferation and IL-2 production
105. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production
106. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to Clq, can enhance FcR and CR1-mediated phagocytosis
107. Effect of SP-A and surfactant lipids on expression of cell surface markers in the THP-1 monocytic cell line
108. Role of cytokines in pulmonary antimicrobial host defense
109. Innate immunity, cytokines, and pulmonary host defense
110. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf)
111. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytoxine secretion by human alveolar macrophages
112. Surfactant suppresses NF-kB activation in human monocytic cells
113. Secretion of surfactant protein A from rat type II pneumocytes
114. Surfactant protein A protects growing cells and reduces TNF-a activity from LPS-stimulated macrophages
115. Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts